Abstract
The 5′ untranslated region of the proto-oncogene c-myc contains an internal ribosome entry segment and c-Myc translation can be initiated by cap-independent as well as cap-dependent mechanisms. In contrast to the process of cap-dependent initiation, the trans-acting factor requirements for cellular internal ribosome entry are poorly understood. Here, we show that members of the poly (rC) binding protein family, poly (rC) binding protein 1 (PCBP1), poly (rC) binding protein 2 (PCBP2) and hnRNPK were able to activate the IRES in vitro up to threefold when added in combination with upstream of N-ras and unr-interacting protein. The interactions of PCBP1, PCBP2 and hnRNPK with c-myc-IRES-RNA were shown to be specific by ultraviolet crosslinking analysis and electrophoretic mobility shift assays, while immunoprecipitation of the three proteins using specific antibodies followed by reverse transcriptase–polymerase chain reaction showed that they were able to bind c-myc mRNA. c-myc–IRES-mediated translation from the reporter vector was stimulated by cotransfection of plasmids encoding PCBP1, PCBP2 and hnRNPK. Interestingly, the mutated version of the c-myc IRES that is prevalent in patients with multiple myeloma bound hnRNPK more efficiently in vitro and was stimulated by hnRNPK to a greater extent in vivo.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Andino R, Boddeker N, Silvera D and Gamarnik AV . (1999). Trends Microbiol., 7, 76–82.
Black DL, Chan R, Min H, Wang J and Bell L . (1998). The Electrophoretic Mobilty Shift Assay for RNA Binding Proteins. Smith CJW (ed). Oxford University Press: Oxford.
Chappell SA, Le Quesne JPC, Paulin FEM, deSchoolmeester ML, Stoneley M, Soutar RL, Ralston SH, Helfrich MH and Willis AE . (2000). Oncogene, 19, 4437–4440.
Creancier L, Morello D, Mercier P and Prats A-C . (2000). J. Cell Biol., 150, 275–281.
Creancier L, Mercier P, Prats A-C and Morello D . (2001). Mol. Cell. Biol., 21, 1833–1840.
Eisenman RN . (2001). Genes Dev., 15, 2023–2030.
Gamarnik AV and Andino R . (1997). RNA, 3, 882–892.
Grandori C, Cowley SM, James LP and Eisenman RN . (2000). Annu. Rev. Cell. Dev. Biol., 16, 653–699.
Gray N and Wickens M . (1998). Annu. Rev. Cell Dev. Biol., 14, 399–458.
Henis-Korenblit S, Shani G, Sines T, Marash L, Shohat G and A K . (2002). Proc. Natl. Acad. Sci., 99, 5400–5405.
Holcik M, Gordon BW and Korneluk RG . (2003). Mol. Cell. Biol., 23, 280–288.
Holcik M and Korneluk RG . (2000). Mol. Cell. Biol., 20, 4648–4657.
Holcik M and Liebhaber SA . (1997). Proc. Natl. Acad. Sci. USA., 94, 2410–2414.
Hunt SL, Hsuan JJ, Totty N and Jackson RJ . (1999). Genes Dev., 13, 437–448.
Jopling CL and Willis AE . (2001). Oncogene, 20, 2664–2670.
Jordan M, Schallhorn A and Wurm F . (1996). Nucleic Acids Res., 24, 596–601.
Kim JH, Hahm B, Kim YK, Chio M and Jang SK . (2000). J. Mol. Biol., 298, 395–340.
LeQuesne JPC, Stoneley M, Fraser GA and Willis AE . (2001). J. Mol Biol., 310, 111–126.
Lomakin IB, Hellen CUT and Pestova TV . (2000). Mol. Cell. Biol., 20, 6019–6029.
Makeyev AV and Liebhaber SA . (2002). RNA, 8, 265–278.
Marcu KB, Bossone SA and Patel AJ . (1992). Annu. Rev. Biochem., 61, 809–860.
Michael WM, Eder PS and Dreyfuss G . (1997). EMBO J., 16, 3587–3598.
Michelotti EF, Michelotti GA, Aronsohn AI and Levens D . (1996a). Mol. Cell. Biol., 16, 2350–2360.
Michelotti GA, Michelotti EF, Pullner A, Duncan RC, Eick D and Levens D . (1996b). Mol. Cell. Biol., 16, 2656–2669.
Mitchell SA, Brown EC, Coldwell MJ, Jackson RJ and Willis AE . (2001). Mol. Cell. Biol., 21, 3364–3374.
Mitchell SA, Spriggs KA, Coldwell MJ, Jackson RJ and Willis AE . (2003). Mol. Cell, 11, 757–771.
Nanbru C, Lafon I, Audiger S, Gensac G, Vagner S, Huez G and Prats A-C . (1997). J. Biol. Chem., 272, 32061–32066.
Niesvizky R, Siegel D and Michaeli J . (1993). Blood Rev., 7, 24–33.
Niranjanakumuri SL, Brazas R and Garcia-Blanco MA . (2002). Methods, 26, 182–190.
Ostarek DH, Ostarek-Lederer A, Wilm M, Thiele BJ, Mann M and Hentze MW . (1997). Cell, 89, 597–606.
Ostarek-Lederer A, Ostarek DH and Hentze MW . (1998). Trends Biochem. Sci., 23, 409–411.
Ostrowski J, Wyrwicz L, Rychlewski L and Bomsztyk K . (2002). J. Biol. Chem., 277, 3603–3610.
Paulin FEM, Chappell SA and Willis AE . (1998). Nucleic Acids Res., 26, 3097–3103.
Paulin FEM, West MJ, Sullivan NF, Whitney RL, Lyne L and Willis AE . (1996). Oncogene, 13, 505–513.
Pilipenko EV, Pestova TV, Kolupaeva VG, Khitrina EV, Poperechnaya AN, Agol VI and Hellen CUT . (2000). Genes Dev., 14, 2028–2045.
Stoneley M . (1998). PhD Thesis, University of Leicester.
Stoneley M, Paulin FEM, Le Quesne JPC, Chappell SA and Willis AE . (1998). Oncogene, 16, 423–428.
Stoneley M, Subkhankulova T, Le Quesne JPC, Coldwell MJ, Jopling CL, Belsham GJ and Willis AE . (2000). Nucleic Acids Res., 28, 687–694.
Thisted T, Lyakhov DL and Liebhaber SA . (2001). J. Biol. Chem., 276, 17484–17496.
Van Seuningen, Ostrowski J and Bomsztyk K . (1995). Biochemistry, 34, 5644–5450.
Walter BL, Nguyen JHC, Ehrenfeld E and BL S . (1999). RNA, 5, 1570–1585.
West MJ, Stoneley M and Willis AE . (1998). Oncogene, 17, 769–780.
West MJ, Sullivan NF and Willis AE . (1995). Oncogene, 13, 2515–2524.
Acknowledgements
This work was funded by grants from the BBSRC (advanced fellowship held by AEW, project grant funding to KAS) and the Wellcome Trust (SAM). JRE was supported by an MRC studentship. Work in KB laboratory is supported by grants form the NIH and JDRF.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Evans, J., Mitchell, S., Spriggs, K. et al. Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo. Oncogene 22, 8012–8020 (2003). https://doi.org/10.1038/sj.onc.1206645
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206645
Keywords
This article is cited by
-
MSI2 promotes translation of multiple IRES-containing oncogenes and virus to induce self-renewal of tumor initiating stem-like cells
Cell Death Discovery (2023)
-
The RNA-binding protein PCBP1 represses lung adenocarcinoma progression by stabilizing DKK1 mRNA and subsequently downregulating β-catenin
Journal of Translational Medicine (2022)
-
Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age
Nature Communications (2022)
-
The role of CSDE1 in translational reprogramming and human diseases
Cell Communication and Signaling (2020)
-
PCBP1 depletion promotes tumorigenesis through attenuation of p27Kip1 mRNA stability and translation
Journal of Experimental & Clinical Cancer Research (2018)